Peripheral Blood Biomarkers Associated With CIPN
NCT02661399 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2020-12-17
Summary
The investigators are doing a research study that will teach us about the tingly pain that people develop when they get chemotherapy.
Conditions
- Peripheral Neuropathy, Secondary to Drugs or Chemicals
Sponsors & Collaborators
-
St. Louis University
lead OTHER
Principal Investigators
-
Jack Lionberger, MD, PhD · St. Louis University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-11-30
- Primary Completion
- 2017-05-08
- Completion
- 2020-12-10
More Related Trials
-
The Effect of Electroacupuncture on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy)
NCT04917796 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Spinal Cord Stimulation for Chemotherapy Induced Peripheral Neuropathy
NCT06596200 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Helping Cancer Patients Manage Neuropathy Symptoms From Chemotherapy With a Low-Intensity, Low-Risk Cranial PEMF Device
NCT07061769 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Establishing of Neuronal-like Cells From Patients With Cisplatin-Induced Peripheral Neuropathy
NCT02492360 ·Status: WITHDRAWN
-
Minocycline Hydrochloride in Reducing Chemotherapy-Induced Peripheral Neuropathy and Acute Pain in Patients With Breast Cancer Undergoing Treatment With Paclitaxel
NCT02297412 ·Status: COMPLETED ·Phase: PHASE2
-
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
NCT04560673 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Investigate the Safety and Efficacy of Ricolinostat
NCT05229042 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating Laser Photobiomodulation for the Treatment of Neuropathic Pain in Chemotherapy-induced Peripheral Neuropathy in Cancer Patients
NCT06834685 ·Status: RECRUITING ·Phase: NA
-
Exploring the Benefit of Topical Capsaicin in Treating Pain From Chemo-induced Peripheral Neuropathy: a Longitudinal Single Center Pilot Study
NCT06744816 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain
NCT06848348 ·Status: RECRUITING ·Phase: PHASE2
-
Capsaicin 179 mg Patch Versus Oral Duloxetine in Patients With Chemotherapy-induced Peripheral Neuropathy
NCT05840562 ·Status: RECRUITING ·Phase: PHASE3
-
Study of Nicotine for Pain Associated With Chemotherapy-Induced Peripheral Neuropathy
NCT04468230 ·Status: TERMINATED ·Phase: PHASE2
-
Scrambler Therapy for Chemotherapy-Induced Peripheral Neuropathy
NCT07219472 ·Status: RECRUITING ·Phase: NA
-
Pilot Study: Impact of Biomarker-Guided Dietary Supplementation on Quality-of-Life Measures in Subjects With Chronic Pain
NCT06247813 ·Status: RECRUITING ·Phase: PHASE2
-
D-cycloserine in the Management of Chemotherapy-Induced Peripheral Neuropathic Pain
NCT00301080 ·Status: TERMINATED ·Phase: PHASE3
-
Neural and Immune Correlates of CIPN and Possible Analgesic Effect of Non-invasive Motor Cortex Stimulation
NCT06522685 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Chemotherapy Induced Peripheral Neuropathy (CIPN) and Lymphoma Longitudinal Follow-up and Prognostic Factors
NCT05378256 ·Status: COMPLETED ·Phase: NA
-
Alpha-lipoic Acid in Patients at Risk for Paclitaxel Induced Neuropathy
NCT01313117 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Fingolimod in Treating Patients With Chemotherapy-Induced Neuropathy
NCT03943498 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Serial Electrophysiologic Monitoring During Administration of Nerve-Toxic Chemotherapeutic Drugs
NCT01208545 ·Status: UNKNOWN
-
Lamotrigine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
NCT00068445 ·Status: COMPLETED ·Phase: PHASE3
-
Topical Menthol for the Treatment of Chemotherapy Induced Peripheral Neuropathy
NCT01855607 ·Status: TERMINATED ·Phase: PHASE2
-
Safety, Tolerability & Pharmacokinetics Study of CNTX-6016 in Healthy Subjects and Subjects With PDN
NCT04857957 ·Status: COMPLETED ·Phase: PHASE1
-
SON-080 in Patients With Persistent Chemotherapy-induced Peripheral Neuropathy (CIPN)
NCT05435742 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Safety and Activity Study of Intrathecally Administered Ziconotide for Neuropathic Pain in Patients With Cancer
NCT00996983 ·Status: UNKNOWN ·Phase: PHASE2